Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach

Hsiao-Hsuan Jen (Contributor)
Wei Jung Chang (Contributor)
Ting Yu Lin (Creator)
Chen Yang Hsu (Creator)
Ming-Fang Yen (Creator)
Chao Chih Lai (Contributor)
Tony Hsiu Hsi Chen (Creator)

School of Oral Hygiene

Dataset

Description

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.<b> </b>

Date made available	2021
Publisher	Adis Journals

DOI
10.6084/m9.figshare.14170898.v1

Access Dataset

Creative Commons Attribution Non Commercial 4.0 International

1 Article

Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach
Jen, H. H., Chang, W. J., Lin, T. Y., Hsu, C. Y., Yen, M.-F., Lai, C. C. & Chen, T. H. H., Jun 2021, In: Infectious Diseases and Therapy. 10, 2, p. 815-825 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)

Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach

Description

DOI

Access Dataset

Research output

Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach

Cite this